Business group Ibec has appointed Paul Duffy, Senior Vice President of Pfizer Global Supply, as its new President for 2023 to 2024.
Mr Duffy succeeds Imelda Hurley, the chief executive of Coillte.
He has worked for Pfizer for more than 30 years and has held multiple roles of increasing responsibility.
Mr Duffy is a current Board Member of Ibec and recently held the position of Chairperson of the Workplace Relations Commission.
Over the years he has been a board member of various organisations, including IDA Ireland, while he was also President of the American Chamber of Commerce.
"It is a privilege to assume the role of Ibec President for the forthcoming 12 months," Mr Duffy said.
Our current strong economic positioning places us at an intriguing juncture, and I firmly believe that this presents us with a remarkable opportunity to progress many aspects of our society," he stated.
He said that undoubtedly, the most significant catalyst for the growth and advancement of the country's industries in Ireland remains the people.
"It is imperative that Ireland continues to excel as country that not only attracts diverse talents but also nurtures their careers, providing an environment that is ideal to live and work. I look forward to engaging with the government on behalf of our members and progressing Ibec's agenda, ensuring Ireland remains a place where businesses and their employees can flourish and thrive," he added.
Ibec CEO Danny McCoy said that with a legacy spanning over 50 years in Ireland, Pfizer stands as a prominent industry leader.
"Paul himself is a distinguished figure in the realms of Irish and European business, and his extensive experience and profound insights will undoubtedly fortify our efforts in the upcoming year as we navigate the intricacies of the economy," Mr McCoy added.
